Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for <i>Helicobacter pylori</i> infection: A randomized, double‐blind, active‐controlled study

Abstract

TBMT showed a noninferior eradication rate and similar adverse events to LBMT as a first-line eradication regimen. Our results suggest that tegoprazan might be substituted for proton pump inhibitors in H. pylori eradication regimens.